MANGOCEUTICALS, INC. Business Finance Contracts & Agreements
35 Contracts & Agreements
- Contribution Agreements (1 contract)
- Note Agreements (3)
- Purchase Agreements (4)
- Registration Rights Agreements (2)
- Stock Agreements (10)
- Subscription Agreements (1)
- Underwriting Agreements (3)
- Waiver Agreements (1)
- Warrant Agreements (10)
- Form of Securities Purchase Agreement relating to the sale of 1,650,000 shares of Series B Convertible Preferred Stock and Warrants to Purchase 1,650,000 shares of Common Stock,... (Filed With SEC on December 26, 2024)
- Form of Common Share Purchase Warrant between Mangoceuticals, Inc. and the holders thereof (December 2024 Offering) (Filed With SEC on December 26, 2024)
- Note Purchase Agreement dated December 13, 2024, by and between Cohen Enterprises, Inc., and Mill End Capital Ltd (Filed With SEC on December 19, 2024)
- Parent Subsidiary Contribution Agreement dated December 13, 2024, by and between Mangoceuticals, Inc. and Mango & Peaches Corp (Filed With SEC on December 19, 2024)
- Patent Purchase Agreement dated December 13, 2024, by and between Mangoceuticals, Inc., as purchaser and Greenfield Investments, Ltd, as seller (Filed With SEC on December 19, 2024)
- $150,000 Promissory Note issued by Mangoceuticals, Inc. in favor of Cohen Enterprises, Inc (Filed With SEC on October 22, 2024)
- Common Share Purchase Warrant dated June 28, 2024 (1,000,000 shares), granted to Platinum Point Capital LLC (Filed With SEC on July 2, 2024)
- Common Share Purchase Warrant dated June 28, 2024 (500,000 shares), granted to Platinum Point Capital LLC (Filed With SEC on July 2, 2024)
- Patent Purchase Agreement dated April 24, 2024, by and between Mangoceuticals, Inc., as purchaser and Intramont Technologies, Inc., as seller (Filed With SEC on April 25, 2024)
- Registration Rights Agreement (ELOC), dated April 4, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Registration Rights Agreement (SPA), dated April 4, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Equity Purchase Agreement dated April 4, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Securities Purchase Agreement dated April 4, 2024, entered into between Mangoceuticals, Inc. and Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Common Share Purchase Warrant dated April 4, 2024 (3,300,000 shares), granted to Platinum Point Capital LLC (Filed With SEC on April 11, 2024)
- Common Stock Purchase Warrant issued by Mangoceuticals, Inc. to Boustead Securities, LLC on January 22, 2024 (Filed With SEC on January 23, 2024)
- Common Stock Purchase Warrant issued by Mangoceuticals, Inc. to Boustead Securities, LLC on December 19, 2023 (Filed With SEC on December 19, 2023)
- Underwriting Agreement, dated December 15, 2023, between Mangoceuticals, Inc. and Boustead Securities, LLC (Filed With SEC on December 19, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated November 1, 2023 between Mangoceuticals, Inc. and Dr. Douglas Christianson (Filed With SEC on December 11, 2023)
- Form of Representatives Warrant (Filed With SEC on December 11, 2023)
- Form of Underwriting Agreement (Filed With SEC on December 11, 2023)
- Common Stock Purchase Warrant granted to Boustead Securities, LLC evidencing the right to acquire 87,500 shares of common stock (dated March 23, 2023) (Filed With SEC on May 10, 2023)
- Stock Option Agreement dated May 1, 2023 between Mangoceuticals, Inc. and Amanda Hammer (150,000 option shares) (Filed With SEC on May 4, 2023)
- Secured Installment Promissory Note dated November 18, 2022, between Mangoceuticals, Inc. and BPI Equipment, Inc (Filed With SEC on February 21, 2023)
- Waiver Agreement dated December 30, 2022, between Mangoceuticals, Inc. and Boustead Securities, LLC (Filed With SEC on January 13, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated October 14, 2022 between Mangoceuticals, Inc. and Lorraine DAlessio (Filed With SEC on January 13, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated October 14, 2022 between Mangoceuticals, Inc. and Alex P. Hamilton (Filed With SEC on January 13, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated October 14, 2022 between Mangoceuticals, Inc. and Dr. Kenny Myers (Filed With SEC on January 13, 2023)
- Notice of Restricted Stock Grant and Restricted Stock Grant Agreement dated October 1, 2022 between Mangoceuticals, Inc. and Eugene M. Johnston (Filed With SEC on January 13, 2023)
- Stock Option Agreement dated August 31, 2022 between Mangoceuticals, Inc. and Jonathan Arango (500,000 option shares) (Filed With SEC on January 13, 2023)
- Stock Option Agreement dated August 31, 2022 between Mangoceuticals, Inc. and Jacob D. Cohen (750,000 option shares) (Filed With SEC on January 13, 2023)
- Form of Subscription Agreement (2022 Private Placement) (Filed With SEC on January 13, 2023)
- Stock Purchase Agreement between American International Holdings Corp. and Cohen Enterprises, Inc., dated June 16, 2022 (Filed With SEC on January 13, 2023)
- Form of Common Stock Purchase Warrant (Investors 2022 Private Placement) (Filed With SEC on January 13, 2023)
- Form of Representatives Warrant (Filed With SEC on January 13, 2023)
- Form of Underwriting Agreement (Filed With SEC on January 13, 2023)
